Clin Ophthalmol
April 2025
Purpose: To evaluate the rotational stability of four different monofocal toric intraocular lenses (IOLs) from surgery to 4-6 months postoperative.
Methods: This was a subset of data from a prospective multi-center randomized clinical study. High resolution retro-illuminated images of eyes implanted with four different toric IOLs were obtained immediately after surgery, and at 1 day, 1 week, 1 month and 4-6 months after surgery.
Purpose: To compare visual performance of the Vivinex Impress enhanced monofocal intraocular lens (IOL) (HOYA Surgical Optics) with the Acrysof IQ monofocal IOL (Alcon Laboratories, Inc).
Methods: In this multicenter, active-controlled trial, participants were randomized 2:1 to bilateral implantation with the enhanced monofocal (test) or standard monofocal (control) IOL and examined through 12 months postoperatively for visual acuities, refractive outcomes, defocus curves, and pupil diameters.
Results: Ninety-eight test and 46 control participants completed testing for the first implanted eye.
Purpose: To evaluate clinical outcomes after bilateral or contralateral implantation of the Gemetric™ (G) and Gemetric™ Plus (GPlus) diffractive trifocal intraocular lenses (IOLs).
Methods: This was a prospective, randomized, multi-center open-label study comparing clinical results and subjective patient responses around 6 months after implantation of the study lenses (toric and non-toric) in three different groups (bilateral G, bilateral GPlus and contralateral G/GPlus implantation). Results included the manifest refraction, uncorrected and distance corrected monocular and binocular visual acuity (VA) at distance, intermediate and near; the defocus curve; contrast sensitivity; and patient reported outcomes regarding spectacle independence, satisfaction and visual disturbances.